基于全身PET的多发性骨髓瘤[11C]蛋氨酸代谢动力学建模
本研究采用uEXPLORER对12名受试者(9例多发性骨髓瘤患者和3名对照)进行全身动态[11C]蛋氨酸PET/CT,通过可逆双组织室模型(2T4k)分析动力学参数。结果显示骨髓瘤病灶的[11C]蛋氨酸净摄取率(Ki)显著高于非骨髓瘤对照,且Ki与M蛋白水平相关,t(4;14)易位患者的k4值升高。基于k4值的代谢分类可能成为多发性骨髓瘤风险分层的有前景策略。
要点
- 骨髓瘤病灶对[11C]蛋氨酸有较高的摄取倾向。
- 血清M蛋白水平与骨髓瘤[11C]蛋氨酸摄取率相关。
- 基于k4值的代谢分类可能是多发性骨髓瘤风险分层的有前景策略。
核心结论
- 多发性骨髓瘤病灶对[11C]蛋氨酸有较高的摄取倾向。
- 血清M蛋白水平与骨髓瘤[11C]蛋氨酸摄取率相关。
- 基于k4值的代谢分类可能是多发性骨髓瘤风险分层的有前景策略。
研究设计与样本
- 研究纳入12名受试者(9例多发性骨髓瘤患者和3名对照),使用uEXPLORER进行全身动态[11C]蛋氨酸PET/CT。
- 提取器官和骨髓的组织时间活度曲线(TACs),使用PMOD动力学建模软件进行模型拟合。
- 经拟合优度(GOF)验证后,采用可逆双组织室模型(2T4k)进一步分析。
- 使用R软件分析动力学参数与临床指标的相关性。
主要发现
- 2T4k通过GOF标准,用于拟合0-20分钟的数据。
- [11C]蛋氨酸净摄取率(Ki)在多发性骨髓瘤病灶中显著高于非骨髓瘤对照(对照:0.040±0.007 mL/g/min,多发性骨髓瘤:0.171±0.108 mL/g/min,p=0.009)。
- Ki值与多发性骨髓瘤患者的M蛋白水平相关。
- t(4;14)易位的多发性骨髓瘤患者k4值高于t(4;14)阴性患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Multiple myeloma (MM) is a malignant disease characterized by the secretion of monoclonal immunoglobulins and has a high demand for amino acids. [11C]methionine total-body PET is capable of noninvasive dynamic monitoring of radiotracer in vivo, thus providing a way to reveal the dynamic changes of myeloma metabolism. This study aims to analyze the metabolic process of [11C]methionine based on kinetic modeling, and to preliminary reveal its application value in MM. METHODS: Dynamic total-body [11C]methionine PET/CT was conducted with uEXPLORER in 12 subjects (9 MM patients and 3 controls). The tissue time activity curves (TACs) of organs and bone marrows were extracted. Model fitting of TACs was operated using PMOD Kinetic Modeling. After validation by Goodness of fit (GOF), the reversible two-tissue compartment model (2T4k) was used to further analysis. R software was used to analyze the correlation between kinetic parameters and clinical indicators. RESULTS: The 2T4k has passed the criterion of GOF and was used to fit the data of 0-20 minutes. The [11C]methionine net uptake rate (Ki) was significantly higher in the MM lesions than in the non-myeloma controls (control: 0.040±0.007 mL/g/min, MM: 0.171±0.108 mL/g/min, p=0.009). The Ki values were found to be correlated with M protein levels in MM patients. MM patients with t(4;14) translocations had an elevated k4 value compared with t(4;14) negative patients. CONCLUSION: MM lesions have a propensity for uptake of [11C]methionine. The serum levels of M protein are correlated with [11C]methionine uptake rate in myeloma. Metabolic classification based on the k4 value may be a promising strategy for risk stratification in MM.
引用
- Li J, Ni B, Yu X, et al. Metabolic kinetic modeling of [11C]methionine based on total-body PET in multiple myeloma. Eur J Nucl Med Mol Imaging. 2023. PMID: 37039900. doi:10.1007/s00259-023-06219-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。